Funding early detection to save lives from pancreatic cancer—faster.
0%
5-Year Survival Rate
0%
Diagnosed Too Late for a Cure
0
New Cases in 2024
0
Deaths in 2024
In almost 9 out of 10 cases, Pancreatic cancer is detected too late for effective treatment.
PRECEDE is building a global early detection network to reverse those odds for good.
What makes PRECEDE different?
PRECEDE unites leading researchers from multiple prestigious institutions and industry partners.
PRECEDE is the only global, open, and collaborative initiative, enabling potentially faster impact than “closed” projects.
PRECEDE bridges the deadly gap between innovative discoveries and lifesaving treatment.
By making a donation to the PRECEDE Foundation, you become a vital part of the movement driving change. Together, we can make a difference and create a future where pancreatic cancer is not only detectable early but also preventable. Your donation allows us to have a meaningful impact on the lives of those affected by pancreatic cancer.
How PRECEDE Saves Lives
PRECEDE proceeds go towards research to detect pancreatic cancers earlier, saving thousands of lives from the world’s deadliest cancer.
This revolutionary effort is for early detection, screening and prevention for pancreatic cancer.
Your donation directly supports this groundbreaking work, including the infrastructure, scientific collaborations, and patient-focused efforts that are accelerating early detection tools with the potential to raise survival rates from 13% to 50%.